BioCryst
Trade BioCryst 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BCRX
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases.
BCRX Key Statistics
Stock Snapshot
BioCryst(BCRX) stock is priced at $9.68, giving the company a market capitalization of 2.46B. It carries a P/E multiple of -5.63.
On 2026-07-01, BioCryst(BCRX) stock traded between a low of $9.59 and a high of $10.15. Shares are currently priced at $9.68, which is +0.9% above the low and -4.7% below the high.
BioCryst(BCRX) shares are trading with a volume of 2.45M, against a daily average of 8.23M.
During the past year, BioCryst(BCRX) stock moved between $6.00 at its lowest and $10.94 at its peak.
During the past year, BioCryst(BCRX) stock moved between $6.00 at its lowest and $10.94 at its peak.
BCRX News
Analyst Andrew Fein of H.C. Wainwright maintained a Buy rating on BioCryst, retaining the price target of $32.00. Unlock powerful investing tools and data-driv...
Cantor Fitzgerald raised the firm’s price target on BioCryst (BCRX) to $29 from $27 and keeps an Overweight rating on the shares. The long-term commercial outlo...
...
Analyst ratings
100%
of 10 ratingsMore BCRX News
Serge Belanger, an analyst from Needham, maintained the Buy rating on BioCryst. The associated price target is $16.00. Unlock powerful investing tools and data...
Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...
Advertisement Recent Orladeyo Data and Revenue Outlook Put BioCryst Pharmaceuticals (BCRX) in Focus Fresh efficacy data for BioCryst Pharmaceuticals (BCRX) le...
Earlier in June 2026, BioCryst Pharmaceuticals reported new clinical and real-world data on its hereditary angioedema therapies ORLADEYO and investigational ant...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.